Trends in antimicrobial resistance among clinical isolates of the Bacteroides fragilis group from 1992 to 1997 in Montreal, Canada

被引：22
|
作者：
Labbé, AC [1 ]
Bourgault, AM [1 ]
Vincelette, J [1 ]
Turgeon, PL [1 ]
Lamothe, F [1 ]
机构：
[1] CHU Montreal, Dept Microbiol Med & Infectiol, Montreal, PQ H2X 3J4, Canada
来源：
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 1999年 / 43卷 / 10期
关键词：
D O I：
10.1128/AAC.43.10.2517
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
The objective of the present study was to analyze the susceptibility profiles of 911 clinical strains of the Bacteroides fragilis group isolated from 1992 to 1997 in our institution in order to monitor susceptibility changes over time. Whereas the rates of resistance to metronidazole, imipenem, piperacillin-tazobactam, ticarcillin-clavulanic acid, penicillin, piperacillin, and cefoxitin remained essentially unchanged, there was a significant increase in the rates of resistance to clindamycin, which rose from 8.2% in 1992 to 19.7% in 1997 (P < 0.0004).
引用
收藏
页码：2517 / 2519
页数：3
相关论文
共 50 条
  • [21] The emergence of antimicrobial resistance in environmental strains of the Bacteroides fragilis group
    Niestepski, Sebastian
    Harnisz, Monika
    Korzeniewska, Ewa
    Guadalupe Aguilera-Arreola, Ma
    Contreras-Rodriguez, Araceli
    Filipkowska, Zofia
    Osinska, Adriana
    ENVIRONMENT INTERNATIONAL, 2019, 124 : 408 - 419
  • [22] Emerging resistance among clinical Bacteroides fragilis isolates in association with nim and cfiA gene
    Gupta, A.
    Chawla, K.
    Shenoy, P. A.
    Kumar, A.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2020, 101 : 25 - 25
  • [23] Antimicrobial resistance patterns of Bacteroides fragilis group organisms in Korea
    Lee, K
    Shin, HB
    Chong, Y
    YONSEI MEDICAL JOURNAL, 1998, 39 (06) : 578 - 586
  • [24] MECHANISM OF RESISTANCE TO CARBAPENEM IN CLINICAL ISOLATES OF BACTEROIDES-FRAGILIS
    PODGLAJEN, I
    BREUIL, J
    RUIMY, R
    BOURGAULT, AM
    BETRIU, C
    CASIN, I
    CHRISTEN, R
    COLLATZ, E
    MEDECINE ET MALADIES INFECTIEUSES, 1994, 24 : 590 - 593
  • [25] The prevalence of enterotoxin and antibiotic resistance genes in clinical and intestinal Bacteroides fragilis group isolates in Turkey
    Kangaba, Achille Aime
    Saglam, Filiz Yarimcam
    Tokman, Hrisi Bahar
    Torun, Mert
    Torun, Muzeyyen Mama
    ANAEROBE, 2015, 35 : 72 - 76
  • [26] Antimicrobial susceptibility of Bacteroides fragilis group isolates in Europe: 20 years of experience
    Nagy, E.
    Urban, E.
    Nord, Carl Erik
    CLINICAL MICROBIOLOGY AND INFECTION, 2011, 17 (03) : 371 - 379
  • [27] Prevalence of in vitro susceptibility to carbapenems among clinical isolates of the Bacteroides fragilis group from a Colombian tertiary hospital
    Salazar, C. L.
    Catano, J. C.
    Molina, D.
    Sierra, P.
    Correa, M.
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2014, 2 (01) : 49 - 51
  • [28] Antimicrobial resistance in the Bacteroides fragilis group in faecal microbiota from healthy Danish children
    Sydenham, Thomas Vognbjerg
    Jensen, Betina Hebbelstrup
    Petersen, Andreas Munk
    Krogfelt, Karen Angeliki
    Justesen, Ulrik Stenz
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2017, 49 (05) : 573 - 578
  • [29] Evaluation of the Disk Diffusion Test for Bacteroides fragilis Group Clinical Isolates
    Lee, Yangsoon
    Bae, Mi-Hyun
    Lee, Hyukmin
    Kim, Myungsook
    Lee, Kyungwon
    ANNALS OF LABORATORY MEDICINE, 2025, 45 (01) : 70 - 76
  • [30] PLASMID ANALYSIS OF CLINICAL ISOLATES OF BACTEROIDES-FRAGILIS GROUP STRAINS
    NAGY, E
    DANYI, E
    FOLDES, J
    ACTA MICROBIOLOGICA HUNGARICA, 1990, 37 (04): : 367 - 373
12345